Celldex Therapeutics CLDX Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$730.0KMiss by $453.9K
EPS-$0.85Beat by $0.01
Revenue estimate$1.2M
EPS estimate-$0.86
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$734.9K
EPS estimate-$1.04
Financials
Q2 2025Valuation & ratios
Segments
By product
Versus estimates
Revenue
Q1 2026$15.0KMiss by $780.4KQ4 2025$100.0KMiss by $1.2M
Q2 2025$730.0KMiss by $453.9K
Q1 2025$695.0KMiss by $425.8KQ4 2024$1.2MMiss by $77.0KDiluted EPS
Ask the moment Celldex Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Celldex Therapeutics report Q2 2025 earnings?
- Celldex Therapeutics (CLDX) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Celldex Therapeutics's Q2 2025 revenue and EPS?
- Celldex Therapeutics reported revenue of $730.0K and eps of $-0.85 for Q2 2025.
- Did Celldex Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $1.2M by $453.9K. EPS beat the consensus estimate of $-0.86 by $0.01.
- How did Celldex Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 70.8% from $2.5M a year earlier and eps declined 57.4% from $-0.54.
- Where can I find Celldex Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001410578-25-001610) directly on SEC EDGAR. The filing index links above go to sec.gov.